Epigenome Technology Exploration Unit, Division of Genomic Technologies, RIKEN Center for Life Science Technologies (CLST), Yokohama, Japan.
Epigenome Technology Exploration Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Sci Rep. 2018 Oct 19;8(1):15499. doi: 10.1038/s41598-018-33779-z.
Osteoarthritis (OA) is a common joint disorder with increasing impact in an aging society. While genetic and transcriptomic analyses have revealed some genes and non-coding loci associated to OA, the pathogenesis remains incompletely understood. Chromatin profiling, which provides insight into gene regulation, has not been reported in OA mainly due to technical difficulties. Here, we employed Assay for Transposase-Accessible Chromatin with high throughput sequencing (ATAC-seq) to map the accessible chromatin landscape in articular knee cartilage of OA patients. We identified 109,215 accessible chromatin regions for cartilages, of which 71% were annotated as enhancers. By overlaying them with genetic and DNA methylation data, we have determined potential OA-relevant enhancers and their putative target genes. Furthermore, through integration with RNA-seq data, we characterized genes that are altered both at epigenomic and transcriptomic levels in OA. These genes are enriched in pathways regulating ossification and mesenchymal stem cell (MSC) differentiation. Consistently, the differentially accessible regions in OA are enriched for MSC-specific enhancers and motifs of transcription factor families involved in osteoblast differentiation. In conclusion, we demonstrate how direct chromatin profiling of clinical tissues can provide comprehensive epigenetic information for a disease and suggest candidate genes and enhancers of translational potential.
骨关节炎(OA)是一种常见的关节疾病,在老龄化社会中的影响日益增加。虽然遗传和转录组分析已经揭示了一些与 OA 相关的基因和非编码基因座,但发病机制仍不完全清楚。染色质谱分析提供了对基因调控的深入了解,但由于技术困难,在 OA 中尚未报道。在这里,我们采用高通量测序的转座酶可及染色质分析(ATAC-seq)来绘制 OA 患者关节膝关节软骨的可及染色质图谱。我们确定了 109,215 个软骨的可及染色质区域,其中 71%被注释为增强子。通过将它们与遗传和 DNA 甲基化数据叠加,我们确定了潜在的 OA 相关增强子及其潜在的靶基因。此外,通过与 RNA-seq 数据的整合,我们描述了在 OA 中在表观基因组和转录组水平上都发生改变的基因。这些基因富集在调节骨化和间充质干细胞(MSC)分化的途径中。一致地,OA 中的差异可及区域富含 MSC 特异性增强子和涉及成骨细胞分化的转录因子家族的基序。总之,我们展示了如何直接对临床组织进行染色质谱分析可以为疾病提供全面的表观遗传信息,并提出了具有转化潜力的候选基因和增强子。